We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Compliance and Administration Technique in Topical Drug Therapy of Glaucoma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00303121
First Posted: March 15, 2006
Last Update Posted: October 11, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Toronto
  Purpose
Clinic-based evaluation of patients compliance with topical medications in the treatment of glaucoma. Also assessing effectiveness of delivery techniques among these patients.

Condition
Glaucoma

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by University of Toronto:

Estimated Enrollment: 120
Study Start Date: November 2005
Estimated Study Completion Date: June 2006
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

glaucoma 18 years of age or older

Exclusion Criteria:

Recent ocular surgery

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00303121


Locations
Canada, Ontario
Toronto Western Hospital
Toronto, Ontario, Canada, M5T 2S8
Sponsors and Collaborators
University of Toronto
Investigators
Principal Investigator: Yvonne M Buys, MD University of Toronto
  More Information

ClinicalTrials.gov Identifier: NCT00303121     History of Changes
Other Study ID Numbers: UHN REB 05-0631-AE
First Submitted: March 14, 2006
First Posted: March 15, 2006
Last Update Posted: October 11, 2006
Last Verified: June 2006

Keywords provided by University of Toronto:
Glaucoma
Compliance
Therapy
Administration technique

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases